You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous Dermatomyositis, Lenalidomide

Showing 1 - 25 of 2,552
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dermatomyositis Trial in Nanchang (Lenalidomide)

Not yet recruiting
  • Dermatomyositis
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Aug 3, 2022

Dermatomyositis Trial in Seattle (Baricitinib)

Not yet recruiting
  • Dermatomyositis
  • Seattle, Washington
    University of Washington Medical Center
Apr 29, 2022

Clinical Responsiveness of Dermatomyositis Using Cutaneous

Recruiting
  • Dermatomyositis
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Jan 29, 2022

    Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

    Recruiting
    • Folliculotropic Mycosis Fungoides
    • +7 more
    • Durvalumab
    • +2 more
    • Duarte, California
    • +3 more
    Jan 12, 2023

    Dermatomyositis, Adult Type Trial in New Orleans (Apremilast 30mg)

    Completed
    • Dermatomyositis, Adult Type
    • Apremilast 30mg
    • New Orleans, Louisiana
      Tulane University
    Jul 7, 2021

    Dermatomyositis, Juvenile Dermatomyositis Trial in Cleveland (H.P. Acthar Gel)

    Completed
    • Dermatomyositis
    • Juvenile Dermatomyositis
    • H.P. Acthar Gel
    • Cleveland, Ohio
      Cleveland Clinic
    Sep 10, 2021

    Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

    Recruiting
    • Cutaneous T-Cell Lymphoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

    Not yet recruiting
    • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
    • +21 more
    • Biopsy
    • +8 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 7, 2023

    Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, Sjogren's Syndrome Trial in Poland, Spain, United States (VIB7734,

    Completed
    • Systemic Lupus Erythematosus
    • +5 more
    • Anniston, Alabama
    • +29 more
    Aug 11, 2020

    Dermatomyositis, Adult Type Trial (Itolizumab)

    Not yet recruiting
    • Dermatomyositis, Adult Type
    • (no location specified)
    Aug 3, 2023

    Lymphoma Trial in Stanford, Chicago, Houston (lenalidomide)

    Completed
    Has Results
    • Lymphoma
    • Stanford, California
    • +2 more
    Nov 13, 2020

    Dermatomyositis, Polymyositis Trial in Orlando (M5049 high dose, Placebo)

    Recruiting
    • Dermatomyositis
    • Polymyositis
    • M5049 high dose
    • Placebo
    • Orlando, Florida
      HMD Research LLC
    Jan 30, 2023

    Severity in Juvenile and Adult-onset Dermatomyositis

    Not yet recruiting
    • Dermatomyositis
    • evaluation of clinical severity
    • (no location specified)
    Aug 16, 2023

    Dermatomyositis Trial in DeBary (GLPG3667, Placebo)

    Not yet recruiting
    • Dermatomyositis
    • DeBary, Florida
      Omega Research Consultants
    Jan 13, 2023

    Dermatomyositis Trial (Interleukin-2)

    Not yet recruiting
    • Dermatomyositis
    • (no location specified)
    Aug 8, 2022

    Polymyositis, Dermatomyositis Trial in Seoul (PN-101)

    Enrolling by invitation
    • Polymyositis
    • Dermatomyositis
    • PN-101
    • Seoul, Korea, Republic of
    • +2 more
    Jun 10, 2022

    Dermatomyositis Trial in Worldwide (Ravulizumab, Placebo)

    Recruiting
    • Dermatomyositis
    • Orange, California
    • +35 more
    Aug 16, 2022

    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +71 more
    • Chicago, Illinois
    • +5 more
    Oct 8, 2021

    Myositis Trial in Upland, Orlando, Saint Louis (PF-06823859, Placebo)

    Recruiting
    • Myositis
    • Upland, California
    • +4 more
    May 29, 2023

    Diffuse Large B Cell Lymphoma Trial in Belgium, France (Lenalidomide, Rituximab)

    Completed
    • Diffuse Large B Cell Lymphoma
    • Antwerpen, Belgium
    • +96 more
    Apr 12, 2021

    Dermatomyositis Trial in Paris (Baricitinib, Placebo)

    Not yet recruiting
    • Dermatomyositis
    • Paris, France
      Pitie-Salpêtrière hospital APHP
    Jun 7, 2022

    Dermatomyositis Trial in Washington (Abatacept)

    Completed
    • Dermatomyositis
    • Washington, District of Columbia
      2300 M Street, 9th floor. Medical Faculty Associates, The George
    Apr 5, 2022

    Polymyositis, Dermatomyositis Trial in Worldwide (KZR-616, Placebo)

    Completed
    • Polymyositis
    • Dermatomyositis
    • Beverly Hills, California
    • +18 more
    Sep 30, 2022

    Treatment Side Effects Trial in Sao Paulo (Lipid-lowering agents (Artovastatin))

    Terminated
    • Treatment Side Effects
    • Lipid-lowering agents (Artovastatin)
    • Sao Paulo, Brazil
      Samuel Katsuyuki Shinjo
    May 31, 2022

    Prevelance Of Cutaneous Disorders Among Heamatologic

    Not yet recruiting
    • Dermatologic Disorders With Heamatologic Malignancies Patients
    • cbc ,u\s renalor hepatic function test if needed
    • Sohag, Egypt
      Sohag university Hospital
    Oct 25, 2023